AAAAAA
Results:
1-12
|
Results: 12
Authors:
Shahedian, B
Shi, YF
Zou, MJ
Farid, NR
Citation: B. Shahedian et al., Thyroid carcinoma is characterized by genomic instability: Evidence from p53 mutations, MOL GEN MET, 72(2), 2001, pp. 155-163
Authors:
Shi, Y
Zou, M
Varkondi, E
Nagy, A
Kozma, L
Farid, NR
Citation: Y. Shi et al., Cyclin D1 in thyroid carcinomas, THYROID, 11(7), 2001, pp. 709-710
Authors:
Farid, NR
Citation: Nr. Farid, P53 mutations in thyroid carcinoma: Tidings from an old foe, J ENDOC INV, 24(7), 2001, pp. 536-545
Authors:
Kong, C
Ellard, S
Johnston, C
Farid, NR
Citation: C. Kong et al., Multiple endocrine neoplasia type 1(Burin) from Mauritius: A novel MEN 1 mutation, J ENDOC INV, 24(10), 2001, pp. 806-810
Authors:
Islam, NM
Hew, CL
Kaczur, V
Farid, NR
Citation: Nm. Islam et al., Cleavage of the thyrotropin receptor, J ENDOC INV, 24(10), 2001, pp. 833-835
Authors:
Nagy, A
Kozma, L
Kiss, I
Ember, I
Takacs, I
Hajdu, J
Farid, NR
Citation: A. Nagy et al., Copy number of cancer genes predict tumor grade and survival of pancreaticcancer patients, ANTICANC R, 21(2B), 2001, pp. 1321-1325
Authors:
Marga, M
Denisova, A
Sochnev, A
Pirags, V
Farid, NR
Citation: M. Marga et al., Two HLA DRB 1 alleles confer independent genetic susceptibility to Graves disease: Relevance of cross-population studies, AM J MED G, 102(2), 2001, pp. 188-191
Authors:
Farid, NR
Kascur, V
Balazs, C
Citation: Nr. Farid et al., The human thyrotropin receptor is highly mutable: a review of gain-of-function mutations, EUR J ENDOC, 143(1), 2000, pp. 25-30
Authors:
Shi, YF
Zou, MJ
Farid, NR
Paterson, MC
Citation: Yf. Shi et al., Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9, BIOCHEM J, 352, 2000, pp. 443-448
Authors:
Kottler, ML
Chauvin, S
Lahlou, N
Harris, CE
Johnston, CJ
Lagarde, JP
Bouchard, P
Farid, NR
Counis, R
Citation: Ml. Kottler et al., A new compound heterozygous mutation of the gonadotropin-releasing hormonereceptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: Chronic estrogen administration amplifies the gonadotropin defect, J CLIN END, 85(9), 2000, pp. 3002-3008
Authors:
Zou, M
Shi, Y
Farid, NR
Al-Sedairy, ST
Paterson, MC
Citation: M. Zou et al., FHIT gene abnormalities in both benign and malignant thyroid tumours, EUR J CANC, 35(3), 1999, pp. 467-472
Authors:
Shi, Y
Parhar, RS
Zou, M
Hammami, MM
Akhtar, M
Lun, ZP
Farid, NR
Al-Sedairy, ST
Paterson, MC
Citation: Y. Shi et al., Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma, BR J CANC, 79(7-8), 1999, pp. 1234-1239
Risultati:
1-12
|